The Korean Journal of Pain

The Korean Pain Society (대한통증학회)
권호 표지
DOI QR코드

DOI QR Code

Ganglion Impar Block With Botulinum Toxin Type A for Chronic Perineal Pain -A Case Report-

  • Lim, Su-Jin (Department of Anesthesiology and Pain Medicine, The Catholic University of Korea College of Medicine) ;
  • Park, Hue-Jung (Department of Anesthesiology and Pain Medicine, The Catholic University of Korea College of Medicine) ;
  • Lee, Sang-Hoon (Department of Anesthesiology and Pain Medicine, The Catholic University of Korea College of Medicine) ;
  • Moon, Dong-Eon (Department of Anesthesiology and Pain Medicine, The Catholic University of Korea College of Medicine)
  • Received : 2009.11.08
  • Accepted : 2009.12.17
  • Published : 2010.03.01
Download PDF
⟨ Previous Next ⟩

Abstract

Chronic perineal pain is an often encountered problem, which produces a great degree of functional impairment and frustration to the patient and a challenge to the treating physician. The reason for this problem is that the region contains diverse anatomic structures with mixed somatic, visceral and autonomic innervations affecting bladder and bowel control and sexual function. A blockade of nociceptive and sympathetic supply to the perineal region, supplied through the ganglion impar has been shown to benefit patients with chronic perineal pain. Several options to this block have been described that chemical neurolysis, radiofrequency ablation etc. Although the analgesic effect of Botulinum toxin type A (BoNT-A) has long been considered secondary to its action for muscle relaxation, BoNT-A also affects the release of the neurotransmitters that are involved in pain perception. We describe a patient who was successfully given ganglion impar block with BoNT-A.

Keywords

References

  1. Toshniwal GR, Dureja GP, Prashanth SM. Transsacrococcygeal approach to ganglion impar block for management of chronic perineal pain: a prospective observational study. Pain Physician 2007; 10: 661-6.
  2. Lee HK, Yang SK, Lee HJ, Lee SY, Kim SM, Kim BS, et al. The effect of ganglion impar block for excessive perianal sweating. Korean J Pain 1995; 8: 363-6.
  3. Kim SK, Ahn CS, Cho YR, Lim SY, Shin KM, Hong SY, et al. Ganglion impar block in the management of rectal tenesmoid pain. Korean J Pain 1996; 9: 226-8.
  4. Reig E, Abejon D, del Pozo C, Insausti J, Contreras R. Thermocoagulation of the ganglion impar or ganglion of Walther: description of a modified approach. Preliminary results in chronic, nononcological pain. Pain Pract 2005; 5: 103-10. https://doi.org/10.1111/j.1533-2500.2005.05206.x
  5. Mahant N, Clouston PD, Lorentz IT. The current use of botulinum toxin. J Clin Neurosci 2000; 7: 389-94. https://doi.org/10.1054/jocn.2000.0684
  6. Welch MJ, Purkiss JR, Foster KA. Sensitivity of embryonic rat dorsal root ganglia neurons to Clostridium botulinum neurotoxins. Toxicon 2000; 38: 245-58. https://doi.org/10.1016/S0041-0101(99)00153-1
  7. Aoki KR. Evidence for antinociceptive activity of botulinum toxin type A in pain management. Headache 2003; 43(Suppl 1): 9-15. https://doi.org/10.1046/j.1526-4610.43.7s.3.x
  8. Cui M, Khanijou S, Rubino J, Aoki KR. Subcutaneous administration of botulinum toxin A reduces formalin-induced pain. Pain 2004; 107: 125-33. https://doi.org/10.1016/j.pain.2003.10.008
  9. Tait RC, Chibnall JT, Krause S. The pain disability index: psychometric properties. Pain 1990; 40: 171-82. https://doi.org/10.1016/0304-3959(90)90068-O
  10. Ailani J, Young WB. The role of nerve blocks and botulinum toxin injections in the management of cluster headaches. Curr Pain Headache Rep 2009; 13: 164-7. https://doi.org/10.1007/s11916-009-0028-7
  11. Carroll I, Clark JD, Mackey S. Sympathetic block with botulinum toxin to treat complex regional pain syndrome. Ann Neurol 2009; 65: 348-51. https://doi.org/10.1002/ana.21601
  12. Jin L, Kollewe K, Krampfl K, Dengler R, Mohammadi B. Treatment of phantom limb pain with botulinum toxin type A. Pain Med 2009; 10: 300-3. https://doi.org/10.1111/j.1526-4637.2008.00554.x
  13. Park HJ, Lee Y, Lee J, Park C, Moon DE. The effects of botulinum toxin A on mechanical and cold allodynia in a rat model of neuropathic pain. Can J Anaesth 2006; 53: 470-7. https://doi.org/10.1007/BF03022619
  14. Ranoux D, Attal N, Morain F, Bouhassira D. Botulinum toxin type A induces direct analgesic effects in chronic neuropathic pain. Ann Neurol 2008; 64: 274-83. https://doi.org/10.1002/ana.21427
  15. Arezzo JC. Possible mechanisms for the effects of botulinum toxin on pain. Clin J Pain 2002; 18(6 Suppl): 125-32. https://doi.org/10.1097/00002508-200211001-00003
  16. Bach-Rojecky L, Lackovic Z. Central origin of the antinociceptive action of botulinum toxin type A. Pharmacol Biochem Behav 2009; 94: 234-8. https://doi.org/10.1016/j.pbb.2009.08.012
  17. Mailis A, Furlan A. Sympathectomy for neuropathic pain. Cochrane Database Syst Rev 2003; 2: CD002918.
  18. Kim HJ, Seo K, Yum KW, Oh YS, Yoon TG, Yoon SM. Effects of botulinum toxin type A on the superior cervical ganglia in rabbits. Auton Neurosci 2002; 102: 8-12. https://doi.org/10.1016/S1566-0702(02)00093-0
  19. Swift A. The current uses of botulinum toxin. Hosp Med 2003; 64: 450-1. https://doi.org/10.12968/hosp.2003.64.8.2257
  20. Radensky PW, Archer JW, Dournaux SF, O'Brien CF. The estimated cost of managing focal spasticity: a physician practice patterns survey. Neurorehabil Neural Repair 2001; 15: 57-68. https://doi.org/10.1177/154596830101500108

Cited by

  1. Obturator Nerve Block with Botulinum Toxin Type B for Patient with Adductor Thigh Muscle Spasm -A Case Report- vol.24, pp.3, 2011, https://doi.org/10.3344/kjp.2011.24.3.164
  2. One is the loneliest number: A review of the ganglion impar and its relation to pelvic pain syndromes pp.08973806, 2013, https://doi.org/10.1002/ca.22193
  3. MR-guided perineural injection of the ganglion impar: technical considerations and feasibility vol.45, pp.5, 2016, https://doi.org/10.1007/s00256-016-2333-7
  4. Conventional Radiofrequency Thermocoagulation vs Pulsed Radiofrequency Neuromodulation of Ganglion Impar in Chronic Perineal Pain of Nononcological Origin pp.1526-4637, 2018, https://doi.org/10.1093/pm/pnx244
  5. Lumbar Sympathetic Block with Botulinum Toxin Type A and Type B for the Complex Regional Pain Syndrome vol.10, pp.4, 2018, https://doi.org/10.3390/toxins10040164
  6. Intractable anal pain in B-cell acute lymphocytic leukemia patients: treatment options vol.32, pp.1, 2019, https://doi.org/10.3344/kjp.2019.32.1.55
  7. Les infiltrations du système nerveux sympathique dans la prise en charge thérapeutiques des douleurs pelvipérinéales chroniques vol.20, pp.12, 2010, https://doi.org/10.1016/j.purol.2010.08.047
  8. Blockade of the Ganglion Impar (Walther), Using Ultrasound and a Loss of Resistance Technique vol.113, pp.1, 2012, https://doi.org/10.14712/23362936.2015.37
  9. Ganglion Impar Blockade: A Review vol.17, pp.1, 2013, https://doi.org/10.1007/s11916-012-0306-7
  10. Evidence-based Clinical Practice Guidelines for Interventional Pain Management in Cancer Pain vol.21, pp.2, 2015, https://doi.org/10.4103/0973-1075.156466
  11. Ultrasound-Guided Nerve Block with Botulinum Toxin Type A for Intractable Neuropathic Pain vol.8, pp.1, 2016, https://doi.org/10.3390/toxins8010018
  12. Long-Term Blood Pressure Control Effect of Celiac Plexus Block with Botulinum Toxin vol.8, pp.2, 2010, https://doi.org/10.3390/toxins8020051
  13. Impar Ganglion Block with Combination of Neurolysis Drugs and Radiofrequency Thermocoagulation for Perineal Pain vol.13, pp.3, 2018, https://doi.org/10.4103/ajns.ajns_306_16
  14. A new technique of ganglion impar pulsed radiofrequency ablation vol.134, pp.10, 2021, https://doi.org/10.1097/cm9.0000000000001423
  15. Effect of botulinum toxin in stellate ganglion for craniofacial hyperhidrosis: a case report vol.49, pp.3, 2010, https://doi.org/10.1177/03000605211004213